"The family physicians and providers in the Guthrie Tunkhannock, PA, office are dedicated to providing patients with the best in personalized services."

During the past decade, Guthrie Foundation For Education And Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Guthrie Foundation For Education And Research" are "Bladder Cancer" (1 trials), "Genetics of Drug Metabolism" (1 trials), "Metastasis" (1 trials), "Ovarian Neoplasm" (1 trials) and "Transitional Cell Carcinoma" (1 trials). Many other conditions were trialed in "Guthrie Foundation For Education And Research" in a lesser frequency.

Most popular intervention types in "Guthrie Foundation For Education And Research" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CT-2103 (poly(L)glutamate-paclitaxel)" (1 trials), "Gemcitabine" (1 trials), "Placebo" (1 trials), "Vinflunine" (1 trials) and "carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guthrie Foundation For Education And Research" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Guthrie Foundation For Education And Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Guthrie Foundation For Education And Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Guthrie Foundation For Education And Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".